Neuronetics (STIM) Net Cash Flow (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,291.01% |
| Dec 31, 2025 | -102.03% |
| Sep 30, 2025 | 552.02% |
| Jun 30, 2025 | -312.92% |
| Mar 31, 2025 | 225.36% |
| Dec 31, 2024 | 73.94% |
| Sep 30, 2024 | -6.19% |
| Jun 30, 2024 | 57.41% |
| Mar 31, 2024 | -150.13% |
| Dec 31, 2023 | 336.93% |
| Sep 30, 2023 | -5.45% |
| Jun 30, 2023 | 35.97% |
| Mar 31, 2023 | -348.84% |
| Dec 31, 2022 | -219.95% |
| Sep 30, 2022 | 127.93% |
| Jun 30, 2022 | 25.54% |
| Mar 31, 2022 | -151.35% |
| Dec 31, 2021 | 67.62% |
| Sep 30, 2021 | -197.58% |
| Jun 30, 2021 | -107.60% |
| Mar 31, 2021 | 4,204.43% |
| Dec 31, 2020 | 46.23% |
| Sep 30, 2020 | 66.04% |
| Jun 30, 2020 | 19.98% |
| Mar 31, 2020 | -81.04% |
| Dec 31, 2019 | 8.41% |
| Sep 30, 2019 | -11.87% |
| Jun 30, 2019 | 22.93% |
| Mar 31, 2019 | -287.55% |
| Dec 31, 2018 | -102.36% |
| Sep 30, 2018 | 1,687.19% |
| Jun 30, 2018 | 33.92% |
| Mar 31, 2018 | -275.93% |
| Dec 31, 2017 | 339.83% |